Authors' Affiliations: 1Department of Medicine, Division of Hematology/Oncology, 2Department of Medicine, Division of Pulmonary Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California; 3Novartis Oncology Translational Medicine, Florham Park, New Jersey; 4Novartis Institutes for BioMedical Research; 5Novartis Pharma AG, Basel, Switzerland; and 6Division of Oncology Translational Medicine, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts(2013-06-01時点)
